Results 131 to 140 of about 12,878,813 (328)

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha   +6 more
wiley   +1 more source

The CMT Model of Free Will [PDF]

open access: yes
Here we propose a compatibilist theory of free will, in the tradition of naturalized philosophy, that attempts: 1) to provide a synthesis of a variety of well-known theories, capable of addressing problems of the latter; 2) to account for the fact that ...
Blusiewicz, Tomasz, Vervoort, Louis
core  

THE FREE AMINO ACIDS OF HUMAN BLOOD PLASMA

open access: hybrid, 1954
William H. Stein, Stanford Moore
openalex   +1 more source

Is Free Education Really Free?

open access: yesPitt Political Review, 2017
The cost of college is remarkable. Shelling out thousands of dollars for some knowledge and a receipt claiming you paid is, in a few words, the modern American college system. Perhaps unsurprisingly, policies have been proposed to reduce the cost of college, even making it free in some instances. On Jan. 9, 2015 President Obama unveiled a plan to make “
openaire   +4 more sources

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy